Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass

Handbook of Pediatric Transfusion Medicine

Volumn , Issue , 2004, Pages 181-189

  Friedman, David F ^a   Montenegro, Lisa M ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84924186803     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012348776-6/50020-0     Document Type: Chapter

References (44)

1. Aharon A, et al. Extracorporeal membrane oxygenation in children after repair of congenital cardiac lesions. Ann Thorac Surg 2001, 72:2095-2102.
2. Azarow K, et al. Congenital diaphragmatic hernia-a tale of two cities: the Toronto experience. J Ped Surgery 1997, 32(3):395-400.
3. Bartlett R, et al. Extracorporeal life support: the University of Michigan experience. JAMA 2000, 283(7):904-908.
4. Butch SH, et al. Blood utilization in adult patients undergoing extracorporeal membrane oxygenated therapy. Transfusion 1996, 36(1):61-63.
5. Chambers L, Cohen D, Davis J Transfusion patterns in pediatric open heart surgery. Transfusion 1996, 36:150-154.
6. Chevuru SC, et al. Multicenter analysis of platelet transfusion usage among neonates on extracorporeal membrane oxygenation. Pediatrics 2002, 109(6).
7. Costello JM, et al. Aprotinin reduces operative closure time and blood product use after pediatric bypass. Ann Thorac Surg 2003, 75(4):1261-1266.
8. Davies M, et al. Prospective, randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations. Ann Thorac Surg 1997, 63:497-503.
9. Despotis G, Hogue C Pathophysiology, prevention, and treatment of bleeding after cardiac surgery: a primer for cardiologists and an update for the cardiothoracic team. Am J Cardiol 1999, 83:15B-30B.
10. Dietrich W Reducing thrombin formation during cardiopul-monary bypass: is there a benefit of the additional anticoagulant action of aprotinin?. J Cardiovasc Physiol 1996, 27(Suppl 1):S50-S57.
11. ELSO Registry ECMO Registry of the Extracorporeal Life Support Organization 1995, http://www.med.umich.edu/ecmo/registry.htm.
12. Foley D, et al. Percutaneous cannulation for pediatric venovenous extracorporeal life support. J Pediatr Surg 2000, 35(6):943-947.
13. Friesen RH, et al. Modified ultrafiltration attenuates dilutional coagulopathy in pediatric open heart operations. Ann Thorac Surg 1997, 64(6):1787-1789.
14. Gaynor J Use of ultrafiltration during and after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg 2001, 122(2):209-211.
15. Green T, et al. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure. Crit Care Med 1996, 24:323-329.
16. Grossi E, et al. Impact of heparin bonding on pediatric cardiopulmonary bypass: a prospective randomized study. Ann Thorac Surg 2000, 70:191-196.
17. Hirschl R Support of respiratory failure in the pediatric surgical patient. Curr Opin Pediatr 2002, 14:459-469.
18. Keshen TH, et al. Does extracorporeal membrane oxygenation benefit neonates with congenital diaphragmatic hernia? Application of a predictive equation. J Ped Surg Perinatol 1997, 32(6):818-822.
19. Kim E, Stolar C ECMO in the newborn. Am J Perinatol 2000, 17(7):345-356.
20. Kwiatkowski JL, Manno CS Blood transfusion support in pediatric cardiovascular surgery. Transfus Sci 1999, 21(1):63-72.
21. Luban N, Strauss R, Hume H Commentary on the safety of red cells preserved in extended-storage media for neonatal transfusions. Transfusion 1991, 31:229-235.
22. Manno C, Hedberg K, Kim H Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991, 77:930-936.
23. Masiakos P, et al. Extracorporeal membrane oxygenation for nonneonatal acute respiratory failure. Arch Surg 1999, 134(4):375-380.
24. McCoy-Pardington D, et al. Blood use during extracorporeal membrane oxygenation. Transfusion 1990, 30:307-309.
25. Menache C, et al. Current incidence of acute neurological complications after open-heart operations in children. Ann Thorac Surg 2002, 73(6):1752-1758.
26. Michael J, et al. Potassium load in CPD-preserved whole blood and two types of packed red blood cells. Transfusion 1975, 15:144-149.
27. Minifee P, et al. Decreasing blood donor exposure in neonates on extracorporeal membrane oxygenation. J Pediatr Surg 1990, 25:38-42.
28. Montenegro L, Greeley W Pro: the use of modified ultrafiltration during pediatric cardiac surgery is a benefit. J Cardiothorac Vasc Anesthesia 1998, 12(4):480-482.
29. Montgomery V, Strotman J, Ross M Impact of multiple organ system dysfunction and nosocomial infections on survival of children treated with extracorporeal membrane oxygenation after heart surgery. Crit Care Med 2000, 28(2):526-531.
30. Mossinger H, Dietrich W Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage. Ann Thorac Surg 1998, 65:S45-S51. (6 Suppl).
31. Mossinger H, et al. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of post-operative ventilation in pediatric cardiac surgery. Ann Thorac Surg 2003, 75(2):430-437.
32. Pelidis MA, et al. Successful treatment of life-threatening acute chest syndrome of sickle cell disease with venovenous extracorporeal membrane oxygenation. J Pediatr Hematol/Oncol 1997, 19(5):459-461.
33. Quattro L, Bowser M, Schwendt A Performing modified ultrafiltration on pediatric patients. AORN Journal 2002, 76(2):300-302.
34. Ramamoorthy C, Lynn A Con: the use of modified ultrafiltration during pediatric cardiac surgery is not a benefit. J Cardiothorac Vasc Anes 1998, 12(4):483-485.
35. Shanley C, et al. Extracorporeal life support for neonatal respiratory failure. A 20-year experience. Ann Surg 1994, 220(3):269-280.
36. Shapira O, et al. Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume. Ann Thorac Surg 1998, 65:724-730.
37. Thompson LD, et al. A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2001, 122(2):220-228.
38. Trant CA, et al. Successful use of extracorporeal membrane oxygenation in the treatment of acute chest syndrome in a child with severe sickle cell anemia. ASAIO Journal 1996, 42(3):236-239.
39. Ungerleider RM Effects of cardiopulmonary bypass and use of modified ultrafiltration. Ann Thorac Surg 1998, 65(6 Suppl):S35-S39.
40. Williams GD, Bratton SL, Ramamoorthy C Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. Anesthesia and Analgesia 1999, 89:57-64.
41. Williams GD, et al. Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. J Cardiothorac Vasc Anes 1999, 13(4):398-404.
42. Williams GD, et al. Fibrinolysis in pediatric patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anes 1998, 12(6):633-638.
43. Wilson JM, et al. Congenital diaphragmatic hernia-a tale of two cities: the Boston experience. J Pediatr Surg 1997, 32(3):401-405.
44. Zavadil DP, et al. Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO). J Extra Corporeal Tech 1998, 30(2):83-90.